| ORGANOGENESIS HLDGS |
| USA |
| Gesundheit |
| US68621F1021 / A2PA31 |
| 2PQ (Frankfurt) / ORGO (NASDAQ) |
| FRA:2PQ, ETR:2PQ, 2PQ:GR, NASDAQ:ORGO |
| - |
| https://organogenesis.com.. |
|
Organogenesis Holdings Inc. is a prominent entity in the biotechnology field, engaged in the development, manufacture, and services related to regenerative medicine products. The company's primary foc..
>Volltext.. |
| 441.91 Mio. EUR |
| 533.38 Mio. EUR |
| 394.14 Mio. EUR |
| 23.85 Mio. EUR |
| 0.85 Mio. EUR |
| -0.08 EUR |
| 34.57 Mio. EUR |
| 54.54 Mio. EUR |
| -32.86 Mio. EUR |
| 0.71 |
| -2.99% |
| - |
| - |
| - |
| - |
| - |
| ORGANOGENESIS |
| 27.02.26 |
|
||||
|
||||
|